Cargando…
Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome
Patients with metabolic syndrome are at a higher risk of nonalcoholic fatty liver disease (NAFLD) and liver fibrosis than the general population. Still, accessibility of screening method for NAFLD with significant fibrosis, such as transient elastography (FibroScan) are limited in some settings. Thi...
Autores principales: | Kositamongkol, Chayanis, Charernboon, Thammanard, Chaisathaphol, Thanet, Washirasaksiri, Chaiwat, Auesomwang, Chonticha, Sitasuwan, Tullaya, Charatcharoenwitthaya, Phunchai, Phisalprapa, Pochamana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568356/ https://www.ncbi.nlm.nih.gov/pubmed/34871234 http://dx.doi.org/10.1097/MD.0000000000027640 |
Ejemplares similares
-
Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients
por: Saokaew, Surasak, et al.
Publicado: (2020) -
Care maps are an effective tool for optimizing quality of care of infectious diseases in a resource-constrained short-stay ambulatory care setting
por: Washirasaksiri, Chaiwat, et al.
Publicado: (2021) -
Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome
por: Boonchai, Punyisa, et al.
Publicado: (2022) -
Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes
por: Washirasaksiri, Chaiwat, et al.
Publicado: (2022) -
Long-Term Outcomes Associated with NAFLD, ASCVD, and All-Cause Mortality of Patients with Metabolic Syndrome
por: Jitrukthai, Suchanart, et al.
Publicado: (2022)